Avosentan (Standard)
Avosentan (Standard) is the analytical standard of Avosentan (HY-15195) . This product is intended for research and analytical applications. Avosentan is an orally active endothelin (ETA) receptor antagonist. Avosentan can block the ETA receptor, thereby reducing vascular contraction, and exerting a renal protective effect. Avosentan inhibits vascular contraction caused by ET-1 and alleviates the reduction in retinal and optic nerve head blood flow induced by it, lowering intraocular pressure in the glaucoma monkey model. Avosentan non-specifically blocks ETB receptors at high doses, inhibiting ETB-mediated diuresis and natriuresis, and may cause fluid retention. Avosentan can be used to reduce proteinuria with diabetic nephropathy, but induces significant fluid overload and congestive heart failure.
Product Specifications
CAS Number
[290815-26-8]
Product Name Alternative
Ro 67-0565 (Standard) ; SPP-301 (Standard)
UNSPSC
12352100
Target
Endothelin Receptor; Reference Standards
Related Pathways
GPCR/G Protein; Others
Field of Research
Cardiovascular Disease; Endocrinology
Smiles
COC1=C(OC(C(NS(C2=NC=C(C=C2)C)(=O)=O)=NC(C3=CC=NC=C3)=N4)=C4OC)C=CC=C1
Molecular Formula
C23H21N5O5S
Molecular Weight
479.51
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Csnk1d, ID (Csnk1d, Hckid, Casein kinase I isoform delta, Tau-protein kinase CSNK1D) (AP)
Csnk1d, ID (Csnk1d, Hckid, Casein kinase I isoform delta, Tau-protein kinase CSNK1D) (AP)
